Novel Mechanisms of Compromised Lymphatic Endothelial Cell Homeostasis in Obesity: The Role of Leptin in Lymphatic Endothelial Cell Tube Formation and Proliferation

PLoS One. 2016 Jul 1;11(7):e0158408. doi: 10.1371/journal.pone.0158408. eCollection 2016.

Abstract

Leptin is a hormone produced by adipose tissue that regulates various physiological processes. Recent studies have shown that the level of circulating leptin is elevated in obese patients and have suggested a relationship between obesity and postoperative lymphedema. However, the mechanisms by which postoperative lymphedema develops in obese patients and the mechanisms by which leptin regulates lymphatic endothelial cell homeostasis such as tube formation and cell proliferation remain unknown. Here we report that leptin regulates tube formation and cell proliferation in human dermal lymphatic endothelial cells (HDLECs) by activation of the signal transducer and activator of transcription 3 pathway, which is downstream signaling of the leptin receptor. Additionally, we found that upregulation of suppressor of cytokine signaling 3 underlies the mechanisms by which a high dose of leptin inhibits cell proliferation and tube formation. Leptin also enhanced expression of the proinflammatory cytokine IL-6 in HDLECs. Interestingly, IL-6 rescues the compromised cell proliferation and tube formation caused by treatment with a high dose of leptin in an autocrine or paracrine manner. Taken together, our findings reveal a novel mechanism by which compromised HDLECs maintain their homeostasis during inflammation mediated by leptin and IL-6. Thus, regulating the level of leptin or IL-6 may be a viable strategy to reduce the incidence of postoperative lymphedema.

MeSH terms

  • Cell Proliferation / drug effects
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelial Cells / pathology*
  • Female
  • Gene Expression Regulation / drug effects
  • Homeostasis* / drug effects
  • Humans
  • Interleukin-6 / genetics
  • Leptin / metabolism*
  • Leptin / pharmacology
  • Middle Aged
  • Obesity / metabolism*
  • Obesity / pathology*
  • Suppressor of Cytokine Signaling 3 Protein / metabolism

Substances

  • Interleukin-6
  • Leptin
  • Suppressor of Cytokine Signaling 3 Protein

Grants and funding

This work was supported by the GSK Japan Research Grant (R.K.) and the Japanese Society for the Promotion of Science (JSPS) grants #26893213 and #15K10787 (R.K.), #15K16399 (A.S.), #15K20214 (K.K.), #26861398 (K.Y.), #26293370 and #26670746 (T.H.), #26670178 and #23590405 (S.I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.